サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672108

世界の放射線腫瘍学市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Radiation Oncology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 162 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
世界の放射線腫瘍学市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線腫瘍学市場規模は、2024年の95億8,000万米ドルから2033年には179億5,000万米ドルに成長し、2026年から2033年の予測期間中に7.23％の堅調な年間平均成長率（CAGR）を示すと予測されています。

放射線腫瘍市場は、がん罹患率の上昇と効果的な治療法に対する需要の高まりに牽引され、大きな成長を遂げようとしています。がんの罹患率は世界的に上昇を続けており、高度な放射線治療ソリューションの必要性はますます高まっています。放射線腫瘍学には、外照射療法、ブラキセラピー、定位放射線手術などのさまざまな技術が含まれ、これらはすべてさまざまな種類のがんの包括的管理に不可欠です。強度変調放射線治療（IMRT）や画像誘導放射線治療（IGRT）などの最先端技術の統合は、治療の精度と有効性を高め、それによって患者の転帰を改善し、副作用を最小限に抑えています。

さらに、放射線腫瘍学技術の進歩が市場内の技術革新を促進しています。陽子線治療やその他の粒子線治療の開発は、腫瘍を効果的に治療しながら健康な組織を温存する標的放射線を提供することで、がん治療に革命をもたらしています。これらの先進的な治療法は、小児患者や重要な構造物の近くに腫瘍がある患者にとって特に有益です。放射線腫瘍学における新たな応用や技術の研究が進むにつれ、治療効果と患者の安全性の向上が期待され、市場はさらに拡大すると思われます。

さらに、個別化医療が重視されるようになり、放射線腫瘍学の展望が形成されつつあります。ヘルスケアプロバイダーが遺伝子や分子プロファイリングに基づいて個々の患者に合わせた治療を求めるようになっているため、個別化された治療計画に沿った放射線治療の需要が高まることが予想されます。この動向は、治療効果を高めるために免疫療法や標的療法と並行して放射線を使用する併用療法に特に関連しています。放射線腫瘍学市場が進化を続ける中、技術の進歩、個別化された治療アプローチ、患者の予後改善への焦点の融合が、将来の軌道を形成する上で重要な役割を果たすと思われます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、最終用途、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 放射線オンコロジーの産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 世界の放射線腫瘍学市場分析：製品タイプ別

  • 概要：製品タイプ別
  • 過去および予測データ分析：製品タイプ別
  • 外部放射線療法
  • 体内照射療法
  • 全身放射線療法

第6章 世界の放射線腫瘍学市場分析：用途別

  • 概要：用途別
  • 過去および予測データ分析：用途別
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 大腸がん
  • 頭頸部がん
  • その他

第7章 世界の放射線腫瘍学市場分析：最終用途別

  • 概要：最終用途別
  • 過去および予測データ分析：最終用途別
  • 病院
  • 外来放射線治療センター
  • がん研究機関
  • その他

第8章 世界の放射線腫瘍学市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他

第9章 放射線腫瘍企業の競合情勢

  • 放射線腫瘍市場競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Varian Medical Systems
  • Elekta
  • Hitachi Medical Corporation
  • IBA Worldwide
  • Accuray Incorporated
  • Advanced Accelerator Applications
  • Nordion Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • External Beam Radiation Therapy Market Sales By Geography (USD MN)
  • Internal Beam Radiation Therapy Market Sales By Geography (USD MN)
  • Systemic Radiation Therapy Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Head and Neck Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Radiotherapy Centers Market Sales By Geography (USD MN)
  • Cancer Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Radiation Oncology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Radiation Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Radiation Oncology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • External Beam Radiation Therapy Market Sales By Geography (USD MN)
  • Internal Beam Radiation Therapy Market Sales By Geography (USD MN)
  • Systemic Radiation Therapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Head and Neck Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Radiotherapy Centers Market Sales By Geography (USD MN)
  • Cancer Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219481

Global Radiation Oncology Market size is anticipated to grow from USD 9.58 Billion in 2024 to USD 17.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.23% during the forecast period of 2026 to 2033.

The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.

Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.

Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
  • Systemic Radiation Therapy

By Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Others

By End-User

  • Hospitals
  • Ambulatory Radiotherapy Centers
  • Cancer Research Institutes
  • Others
  • COMPANIES PROFILED
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Varian Medical Systems
  • Elekta
  • Hitachi Medical Corporation
  • IBA Worldwide
  • Accuray Incorporated
  • Advanced Accelerator Applications
  • Nordion Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. RADIATION ONCOLOGY a€" INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. External Beam Radiation Therapy Historic and Forecast Sales By Regions
  • 5.4. Internal Beam Radiation Therapy Historic and Forecast Sales By Regions
  • 5.5. Systemic Radiation Therapy Historic and Forecast Sales By Regions

6. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Breast Cancer Historic and Forecast Sales By Regions
  • 6.4. Lung Cancer Historic and Forecast Sales By Regions
  • 6.5. Prostate Cancer Historic and Forecast Sales By Regions
  • 6.6. Colorectal Cancer Historic and Forecast Sales By Regions
  • 6.7. Head and Neck Cancer Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Radiotherapy Centers Historic and Forecast Sales By Regions
  • 7.5. Cancer Research Institutes Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIATION ONCOLOGY COMPANIES

  • 9.1. Radiation Oncology Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF RADIATION ONCOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Siemens Healthineers
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. GE Healthcare
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Philips Healthcare
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Varian Medical Systems
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Elekta
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Hitachi Medical Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IBA Worldwide
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Accuray Incorporated
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Advanced Accelerator Applications
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Nordion Inc
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies